|
Targeting CD44-Moesin Interactions with Small Molecules for Alzheimer’s Disease
This technology is a small molecule compound that could serve as a potential therapeutic for Alzheimer’s Disease (AD). The compound binds to Moesin, a protein that is associated with AD. It targets interactions between Moesin and CD44, an antigen that also has been shown to be a biomarker for AD. Targeting CD44 and Moesin interactions has proved...
Published: 4/3/2023
|
Inventor(s): May Khanna, Judith Tello Vega, Haley Williams, Vijay Gokhale, Marcel Patek, Jake Carlson
Keywords(s):
Category(s): Technology Classifications > Life Sciences
|
